ArticleScientific reports2025
Intra-scale interaction and cross-scale fusion network for detecting the progression of neurodegeneration in Alzheimer's disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer’s disease (AD), one of the most widespread neurodegenerative disorders, can be mitigated through early recognition and treatment. Recent research has shown that multimodal fusion is effective for the early-stage diagnosis of AD. However, most existing methods do not adequately account for the differences in data modality domains, their interconnections, and relative relevance.In this paper, we introduce a robust Intra-scale Interaction and Cross-scale Fusion Network (ISI-CSFN) for AD progression detection. The proposed model employs a linearized convolutional attention module to enable interaction between global information captured by the Cascaded Transformer (CTransformer) and local features extracted by the Depthwise Separable Convolution Network (DSCN). This mechanism enhances the discriminative ability for AD progression detection by allowing each modality-specific branch to incorporate complementary contextual representations from the others while maintaining the integrity of its own features.Furthermore, the model integrates background (BG) information with multimodal temporal data for simultaneous prediction of several cognitive score variables. The proposed method achieves strong results for both regression and multi-class progression tasks. Specifically, the accuracy of our approach is 97.26% for NC vs. AD, 89.25% for NC vs. sMCI, and 84.74% for NC vs. pMCI classifications. In addition, the model attains the highest correlation coefficient and the lowest root mean square error (RMSE) across several clinical score regression tasks.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.